Obesity and cytokines in childhood-onset systemic lupus erythematosus

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Sinicato, Nailú Angélica ^a   Postal, Mariana ^a   Peres, Fernando Augusto ^a   Peliçari, Karina De Oliveira ^a   Marini, Roberto ^a   Dos Santos, Allan De Oliveira ^a   Ramos, Celso Dario ^a   Appenzeller, Simone ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADOLESCENT; BLOOD; BODY COMPOSITION; BODY MASS; CASE CONTROL STUDY; CHILD; COMPLICATION; FEMALE; HUMAN; MALE; OBESITY; ONSET AGE; SYSTEMIC LUPUS ERYTHEMATOSUS; YOUNG ADULT;

ADOLESCENT; AGE OF ONSET; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; CYTOKINES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; OBESITY; YOUNG ADULT;

EID: 84896967884     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/162047     Document Type: Article

References (59)

1. Danchenko N., Satia J. A., Anthony M. S., Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006 15 5 308 318 2-s2.0-33744822178 10.1191/0961203306lu2305xx (Pubitemid 43828810)
2. Merrell M., Shulman L. E., Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. Journal of Chronic Diseases 1955 1 1 12 32 2-s2.0-49749200274
3. Svenungsson E., Jensen-Urstad K., Heimbürger M., Silveira A., Hamsten A., De Faire U., Witztum J. L., Frostegård J., Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001 104 16 1887 1893 2-s2.0-0035899949 (Pubitemid 32983229)
4. Poirier P., Giles T. D., Bray G. A., Hong Y., Stern J. S., Pi-Sunyer F. X., Eckel R. H., Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 american heart association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation 2006 113 6 898 918 2-s2.0-33644850953 10.1161/CIRCULATIONAHA.106. 171016
5. Wang Z., Nakayama T., Inflammation, a link between obesity and cardiovascular disease. Mediators of Inflammation 2010 2010 17 2-s2.0-77956869772 10.1155/2010/535918 535918
6. Fantuzzi G., Mazzone T., Adipose tissue and atherosclerosis: exploring the connection. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 5 996 1003 2-s2.0-34247325960 10.1161/ATVBAHA.106.131755 (Pubitemid 46641984)
7. Melmer A., Lamina C., Tschoner A., Ress C., Kaser S., Laimer M., Sandhofer A., Paulweber B., Ebenbichler C. F., Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors. Obesity 2013 21 4 775 781 10.1002/oby.20289
8. Parker B., Bruce I. N., The metabolic syndrome in systemic lupus erythematosus. Rheumatic Disease Clinics of North America 2010 36 1 81 97 2-s2.0-77349091591 10.1016/j.rdc.2009.12.004
9. Ota T., Chemokine systems link obesity to insulin resistance. Journal of Diabetes & Metabolism 2013 37 3 165 172 10.4093/dmj.2013.37.3.165
10. Postal M., Appenzeller S., The role of Tumor Necrosis Factor-alpha (TNF- α) in complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus. Arthritis Research & Therapy 2003 5 172 177
11. Cross J. T., Benton H. P., The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus. Inflammation Research 1999 48 5 255 261 2-s2.0-0033066019 10.1007/s000110050456 (Pubitemid 29257616)
12. Pittas A. G., Joseph N. A., Greenberg A. S., Adipocytokines and insulin resistance. Journal of Clinical Endocrinology and Metabolism 2004 89 2 447 452 2-s2.0-1442327902 10.1210/jc.2003-031005 (Pubitemid 38269842)
13. Welsh P., Murray H. M., Ford I., Trompet S., De Craen A. J., Jukema J. W., Stott D. J., McInnes I. B., Packard C. J., Westendorp R. G., Sattar N., Circulating interleukine-10 and risk of cardiovascular disease events: a prospective study in the elderly at risk. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 10 2338 2344 10.1161/ATVBAHA.111.231795
14. Pinderski L. J., Fischbein M. P., Subbanagounder G., Fishbein M. C., Kubo N., Cheroutre H., Curtiss L. K., Berliner J. A., Boisvert W. A., Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circulation Research 2002 90 10 1064 1071 2-s2.0-0037205317 10.1161/01.RES. 0000018941.10726.FA (Pubitemid 34627904)
15. Thüsen J. H. V. D., Kuiper J., Fekkes M. L., De Vos P., Van Berkel T. J., Biessen E. A., Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDL r-/-mice. The FASEB Journal 2001 15 14 2730 2732 2-s2.0-0035653435
16. Coelho M., Oliveira T., Fernandes R., Biochemistry of adipose tissue: an endocrine organ. Archives of Medical Science 2013 9 2 191 200 10.5114/aoms.2013.33181
17. Grunfeld C., Gulli R., Moser A. H., Gavin L. A., Feingold K. R., Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. Journal of Lipid Research 1989 30 4 579 585 2-s2.0-0024600778 (Pubitemid 19107744)
18. Feingold K. R., Soued M., Staprans I., Gavin L. A., Donahue M. E., Huang B.-J., Moser A. H., Gulli R., Grunfeld C., Effect of Tumor Necrosis Factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. Journal of Clinical Investigation 1989 83 4 1116 1121 2-s2.0-0024516278 (Pubitemid 19113022)
19. Hochberg M. C., Updating the american college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 1997 40 9 1725 2-s2.0-0031229830
20. Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H., Austin A., Bell A., Bloch D. A., Corey P. N., Decker J. L., Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis and Rheumatism 1992 35 6 630 640 2-s2.0-0026777352 10.1002/art.1780350606
21. Yee C.-S., Farewell V. T., Isenberg D. A., Griffiths B., Teh L.-S., Bruce I. N., Ahmad Y., Rahman A., Prabu A., Akil M., McHugh N., Edwards C., D'Cruz D., Khamashta M. A., Gordon C., The use of systemic lupus erythematosus disease activity index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology 2011 50 5 982 988 2-s2.0-79955126646 10.1093/ rheumatology/keq376
22. Ibañez D., Urowitz M. B., Gladman D. D., Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. Journal of Rheumatology 2003 30 9 1977 1982 2-s2.0-0043195825 (Pubitemid 37075547)
23. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., Bacon P., Bombardieri S., Hanly J., Hay E., Isenberg D., Jones J., Kalunian K., Maddison P., Nived O., Petri M., Richter M., Sanchez-Guerrero J., Snaith M., Sturfelt G., Symmons D., Zoma A., The development and initial validation of the systemic lupus international collaborating clinics/american college of rheumatology damage index for systemic lupus erythematosus. Arthritis and Rheumatism 1996 39 3 363 369 2-s2.0-13344270914 10.1002/art.1780390303 (Pubitemid 26085211)
24. World Health Organization, Obesity: preventing and managing the global epidemic. WHO Technical Report Series 2000 no. 894
25. Conde W. L., Monteiro C. A., Body mass index cutoff points for evaluation of nutritional status in brazilian children and adolescents. Jornal de Pediatria 2006 82 4 266 272 2-s2.0-33747344207 10.2223/JPED.1502
26. Rodríguez-Hernández H., Simental-Mendía L. E., Rodríguez-Ramírez G., Reyes-Romero M. A., Obesity and inflammation: epidemiology, risk factors and markers of inflammation. International Journal of Endocrinology 2013 2013 11 678159 10.1155/2013/678159
27. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485 (Pubitemid 46024993)
28. Escárcega R. O., García-Carrasco M., Fuentes-Alexandro S., Jara L. J., Rojas-Rodriguez J., Escobar-Linares L. E., Cervera R., Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease. Autoimmunity Reviews 2006 6 1 48 53 2-s2.0-33751219892 10.1016/j.autrev.2006.07.001 (Pubitemid 44781092)
29. Pi-Sunyer F. X., The obesity epidemic: pathophysiology and consequences of obesity. Obesity Research 2002 10 2 97S 104S 2-s2.0-0042484813 (Pubitemid 41132563)
30. Caballero A. E., Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obesity Research 2003 11 11 1278 1289 2-s2.0-1542545604 (Pubitemid 41127348)
31. Berg A. H., Scherer P. E., Adipose tissue, inflammation, and cardiovascular disease. Circulation Research 2005 96 9 939 949 2-s2.0-19044393872 10.1161/01.RES.0000163635.62927.34 (Pubitemid 40712793)
32. Lau D. C. W., Dhillon B., Yan H., Szmitko P. E., Verma S., Adipokines: molecular links between obesity and atheroslcerosis. American Journal of Physiology-Heart and Circulatory Physiology 2005 288 5 H2031 H2041 2-s2.0-18044366410 10.1152/ajpheart.01058.2004 (Pubitemid 40604084)
33. Oeser A., Chung C. P., Asanuma Y., Avalos I., Stein C. M., Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis and Rheumatism 2005 52 11 3651 3659 2-s2.0-27744600326 10.1002/art.21400 (Pubitemid 41612237)
34. Ghanim H., Aljada A., Hofmeyer D., Syed T., Mohanty P., Dandona P., Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004 110 12 1564 1571 2-s2.0-4644338458 10.1161/01.CIR.0000142055. 53122.FA (Pubitemid 39297977)
35. Garaulet M., Perez-Llamas F., Fuente T., Zamora S., Tebar F. J., Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. European Journal of Endocrinology 2000 143 5 657 666 2-s2.0-0033674551
36. Katsuki A., Sumida Y., Murashima S., Murata K., Takarada Y., Ito K., Fujii M., Tsuchihashi K., Goto H., Nakatani K., Yano Y., Serum levels of tumor necrosis factor- α are increased in obese patients with noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1998 83 3 859 862 2-s2.0-15644362064 10.1210/jc.83.3.859 (Pubitemid 28496458)
37. Bertin E., Nguyen P., Guenounou M., Durlach V., Potron G., Leutenegger M., Plasma levels of Tumor Necrosis Factor-alpha (TNF- α) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes and Metabolism 2000 26 3 178 182 2-s2.0-0033920370 (Pubitemid 30435762)
38. Pedersen M., Bruunsgaard H., Weis N., Hendel H. W., Andreassen B. U., Eldrup E., Dela F., Pedersen B. K., Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mechanisms of Ageing and Development 2003 124 4 495 502 2-s2.0-0037397789 10.1016/S0047-6374(03)00027-7 (Pubitemid 36514904)
39. Luz L. P., Favarato D., Chronic cardiac disease. Arquivos Brasileiros de Cardiologia 1999 72 5 21
40. Kern P. A., Saghizadeh M., Ong J. M., Bosch R. J., Deem R., Simsolo R. B., The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. Journal of Clinical Investigation 1995 95 5 2111 2119 2-s2.0-0028968879
41. Hotamisligil G. S., Arner P., Caro J. F., Atkinson R. L., Spiegelman B. M., Increased adipose tissue expression of tumor necrosis factor- α in human obesity and insulin resistance. Journal of Clinical Investigation 1995 95 5 2409 2415 2-s2.0-0028931724
42. Wykretowicz A., Furmaniuk J., Smielecki J., Deskur-Smielecka E., Szczepanik A., Banaszak A., Wysocki H., The oxygen stress index and levels of circulating interleukin-10 and interleukin-6 in patients with chronic heart failure. International Journal of Cardiology 2004 94 2-3 283 287 2-s2.0-1842828868 10.1016/j.ijcard.2003.06.001 (Pubitemid 38490674)
43. Kern P. A., Saghizadeh M., Ong J. M., Bosch R. J., Deem R., Simsolo R. B., The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. Journal of Clinical Investigation 1995 95 5 2111 2119 2-s2.0-0028968879
44. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D. R., Miles J. M., Yudkin J. S., Klein S., Coppack S. W., Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor- α in vivo. Journal of Clinical Endocrinology and Metabolism 1997 82 12 4196 4200 2-s2.0-0030735542 (Pubitemid 27525539)
45. Bruun J. M., Verdich C., Toubro S., Astrup A., Richelsen B., Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor- α. Effect of weight loss in obese men. European Journal of Endocrinology 2003 148 5 535 542 2-s2.0-0037763758 10.1530/eje.0.1480535 (Pubitemid 36622161)
46. Linker-Israeli M., Deans R. J., Wallace D. J., Prehn J., Ozeri-Chen T., Klinenberg J. R., Elevated levels of endogenous IL-6 in systemic lupus erythematosus: a putative role in pathogenesis. Journal of Immunology 1991 147 1 117 123 2-s2.0-0025990288
47. Grondal G., Gunnarsson I., Ronnelid J., Rogberg S., Klareskog L., Lundberg I., Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clinical and Experimental Rheumatology 2000 18 5 565 570 2-s2.0-0033808893
48. Park Y. B., Lee S. K., Kim D. S., Lee J., Lee C. H., Song C. H., Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clinical and Experimental Rheumatology 1998 16 3 283 288 2-s2.0-0031961344 (Pubitemid 28219167)
49. Beebe A. M., Cua D. J., De Waal Malefyt R., The role of interleukin-10 in autoimmune disease: Systemic Lupus Erythematosus (SLE) and multiple sclerosis (MS). Cytokine and Growth Factor Reviews 2002 13 4-5 403 412 2-s2.0-0036695207 10.1016/S1359-6101(02)00025-4
50. Girndt M., Köhler H., Interleukin-10 (IL-10): an update on its relevance for cardiovascular risk. Nephrology Dialysis Transplantation 2003 18 10 1976 1979 2-s2.0-0141507033 10.1093/ndt/gfg311 (Pubitemid 37220299)
51. Ripley B. J. M., Goncalves B., Isenberg D. A., Latchman D. S., Rahman A., Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia. Annals of the Rheumatic Diseases 2005 64 6 849 853 2-s2.0-19544390172 10.1136/ard.2004.022681 (Pubitemid 40733907)
52. Skamra C., Ramsey-Goldman R., Management of cardiovascular complications in systemic lupus erythematosus. International Journal of Clinical Rheumatology 2010 5 1 75 100 2-s2.0-77950205354 10.2217/ijr.09.73
53. Sabio J. M., Vargas-Hitos J., Zamora-Pasadas M., Mediavilla J. D., Navarrete N., Ramirez Á., Hidalgo-Tenorio C., Jáimez L., Martín J., Jiménez-Alonso J., Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus. Journal of Rheumatology 2009 36 10 2204 2211 2-s2.0-70450172628 10.3899/jrheum.081253
54. Fried S. K., Bunkin D. A., Greenberg A. S., Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. Journal of Clinical Endocrinology and Metabolism 1998 83 3 847 850 2-s2.0-0031762908 10.1210/jc.83.3.847 (Pubitemid 28496456)
55. Haddy N., Sass C., Droesch S., Zaiou M., Siest G., Ponthieux A., Lambert D., Visvikis S., IL-6, TNF- α and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis 2003 170 2 277 283 2-s2.0-0242661399 10.1016/S0021-9150(03)00287-9 (Pubitemid 37377800)
56. Lupus Fundation of America,. 2013, http://www.lupus.org/
57. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines, Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis & Rheumatism 1999 42 9 1785 1796
58. Bertsias G. K., Ioannidis J. P. A., Boletis J., Bombardieri S., Cervera R., Dostal C., Font J., Gilboe I. M., Houssiau F., Huizinga T., Isenberg D., Kallenberg C. G. M., Khamashta M., Piette J. C., Schneider M., Smolen J., Sturfelt G., Tincani A., Van Vollenhoven R., Gordon C., Boumpas D. T., EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics. Annals of the Rheumatic Diseases 2008 67 2 195 205 2-s2.0-38749089852 10.1136/ard.2007.070367 (Pubitemid 351183308)
59. Maidhof W., Hilas O., Lupus: an overview of the disease and management options. Pharmacy and Therapeutics 2012 37 4 240 246